Virtus LifeSci Biotech Products ETF
12 hedge funds and large institutions have $3.52M invested in Virtus LifeSci Biotech Products ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$177K | |
| 2 | +$43.9K | |
| 3 | +$43K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$588 |
Top Sellers
| 1 | -$143K | |
| 2 | -$35.2K | |
| 3 | -$30.2K | |
| 4 |
Goldman Sachs
New York
|
-$29.4K |
| 5 |
TSMHT
Thurston Springer Miller Herd & Titak
Indianapolis,
Indiana
|
-$28.3K |